These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development of a vestibular schwannoma tumor slice model for pharmacological testing. Nickl V; Fakler J; Ziebolz D; Rumpel C; Stabenow L; Bernhagen J; Rampeltshammer E; Ernestus RI; Löhr M; Gugel I; Matthies C; Monoranu CM; Hagemann C; Breun M J Neurosci Methods; 2024 May; 405():110082. PubMed ID: 38387803 [TBL] [Abstract][Full Text] [Related]
4. Single-cell transcriptomes reveal the heterogeneity and microenvironment of vestibular schwannoma. Huo Z; Wang Z; Luo H; Maimaitiming D; Yang T; Liu H; Li H; Wu H; Zhang Z Neuro Oncol; 2024 Mar; 26(3):444-457. PubMed ID: 37862593 [TBL] [Abstract][Full Text] [Related]
5. Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations. Nickl V; Ziebolz D; Rumpel C; Klein D; Nickl R; Rampeltshammer E; Monoranu CM; Ernestus RI; Matthies C; Löhr M; Hagemann C; Breun M Front Oncol; 2024; 14():1340184. PubMed ID: 38817895 [TBL] [Abstract][Full Text] [Related]
6. A Novel Multi-Model High Spatial Resolution Method for Analysis of DCE MRI Data: Insights from Vestibular Schwannoma Responses to Antiangiogenic Therapy in Type II Neurofibromatosis. Li KL; Lewis D; Zhu X; Coope DJ; Djoukhadar I; King AT; Cootes T; Jackson A Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765090 [TBL] [Abstract][Full Text] [Related]
7. Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis. Egiz A; Nautiyal H; Alalade AF; Gurusinghe N; Roberts G J Neurooncol; 2022 Aug; 159(1):135-150. PubMed ID: 35761159 [TBL] [Abstract][Full Text] [Related]
9. The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study. Lewis D; Donofrio CA; O'Leary C; Li KL; Zhu X; Williams R; Djoukhadar I; Agushi E; Hannan CJ; Stapleton E; Lloyd SK; Freeman SR; Wadeson A; Rutherford SA; Hammerbeck-Ward C; Evans DG; Jackson A; Pathmanaban ON; Roncaroli F; King AT; Coope DJ J Neurosurg; 2021 May; 134(5):1419-1429. PubMed ID: 32470937 [TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
11. Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics. de Vries M; van der Mey AG; Hogendoorn PC Otol Neurotol; 2015 Aug; 36(7):1128-36. PubMed ID: 26049313 [TBL] [Abstract][Full Text] [Related]
12. Giant Sporadic Unilateral Vestibular Schwannoma in Child: Can It Get Bigger Than This? Rafiq R; Sharma R; Borkar SA World Neurosurg; 2019 Oct; 130():378-379. PubMed ID: 31306840 [TBL] [Abstract][Full Text] [Related]
13. M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma. de Vries WM; Briaire-de Bruijn IH; van Benthem PPG; van der Mey AGL; Hogendoorn PCW Virchows Arch; 2019 Mar; 474(3):375-381. PubMed ID: 30580386 [TBL] [Abstract][Full Text] [Related]